Company is listed on Bombay Stock Exchange and the National Stock Exchange in India. The Company was established in 1995 and has two divisions:

Agri Bio Sciences division:
The product range includes Herbal-based Nutraceuticals for management of lifestyle diseases.
Company has its floriculture operations cultivating, processing and exporting cut flower roses. The company over the past 15 years has grown and expanded its agriculture operations into floriculture, nursery, contract farming and procurement and trading of agri-commodities. The Company also diversified into manufacturing and outsourcing of herbal extracts, formulations and dietary supplements for life style disease management, which include Bio-Nutraceuticals, Nutritional products, Fortified Proteins and Natural Oxidants, Probiotics and Prebiotic, Alpha- Omega Fatty Acids.

Biologics and Life Sciences Division:
Established in 2009, the state of the art multi-product USFDA compliant Bio-Pharma unit spreads over 3.86 acres of land. This plant shall utilize cell fusion techniques, hybidomas recombinant DNA technology, protein engineering, bacterial expressions and structure based molecular design which is part of modern Biotechnology.
The product range shall include Biosimilar products, such as Vaccines, synthetic therapeutic peptides, Probiotics, Proteins, different parenteral formulations (anticancer, antimalarial, antibiotics, antiviral, anemia, etc.) and dietary supplements.
This division requires this round of funding to start operations.

Aggressive Expansion:
Company has completed its Phase 1 expansion (spending $9mn) and additionally has spent $3mn for the required infrastructure of Phase 2 for its Biotech division.
Due to this aggressive expansion and overleveraging, recently the Bank put the Company operations on hold due to its inability to service the outstanding loans. Thus the need for injecting additional capital.

Company requires additional $13.5mn to service part of its loans and complete its Phase 2 expansion. Funding can be in the form of debt or preferred shares.

Financials: in USD mn
Years Revenues EBITDA
2020 77 29
2019 51 18
2018 33 7
2017 20 4
2016 17 2
2015 20 3.5
2014 19 3.5
2013 20 3

Posted Jun 6, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Suggested Searches

Disclaimer: MergerNetwork has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.